loading animation for AJAX calls

Market research reports on:  DNA, RNA, proteomics, genomics, genetics, cancer, cell, protein, sequencing, biomarkers, peptides, in vitro diagnostics, molecular and others.

Let's Connect

334 Reports in Cell Biology

Cancer Cell Analysis, Instruments, Consumables and Reagents

Published - Jan 2019 | Publisher - BCC Publishing| Code - BIO177A

The global market for cancer cell analysis should reach $10.8 billion by 2023 from $7.4 billion in 2018 at a compound annual growth rate (CAGR) of 7.8% for the period of 2018-2023.

Cell Separation and Characterization in Solid Tumors: Global Mark...

Published - Jan 2019 | Publisher - BCC Publishing| Code - BIO167A

The global market for cell separation and characterization in solid tumors should grow from $1.8 billion in 2018 to reach $3.3 billion by 2023 at a compound annual growth rate (CAGR) of 12.5% for the period of 2018-2023.

Bioprocess Optimization and Digital Bio-manufacturing: Global Mar...

Published - Jan 2019 | Publisher - BCC Publishing| Code - BIO170A

The global market for bioprocess optimization and digital biomanufacturing will grow from nearly $26.5 billion in 2018 to nearly $40.5 billion by 2023 with a compound annual growth rate (CAGR) of 8.9% for the period of 2018-2023.

Biomarker Deals: Terms, Value and Trends, 2008-2018

Published - Jan 2019 | Publisher - BCC Publishing| Code - BIO169A

Over the last decade, biomarker research has become one of the essential aspects not only of the in vitro diagnostics industry but an important component of the drug discovery and development process. Moreover, with the growing trend in personalized medicine and companion diagnostics, the use of biomarkers is becoming obligatory in management of certain diseases, such as cancer drug regimen.

Chromatography in Pharmaceuticals and Biotechnology: Global Marke...

Published - Dec 2018 | Publisher - BCC Publishing| Code - BIO163A

The global market for chromatography instruments and reagents should grow from $9.8 billion in 2018 to $14.0 billion in 2023 at a compound annual growth rate (CAGR) of 7.3% from 2018 to 2023.

Cell-based Assays: Technologies and Global Markets

Published - Dec 2018 | Publisher - BCC Publishing| Code - BIO080D

The global market for cell-based assays should grow from $20.1 billion in 2018 to $32.7 billion by 2023 at a compound annual growth rate (CAGR) of 10.2% from 2018 through 2023.

High Content Screening/Imaging: Technologies and Global Markets

Published - Nov 2018 | Publisher - BCC Publishing| Code - BIO166A

The global market for high content screening/imaging should grow from $915.0 million in 2018 to reach $1.7 billion by 2023 at a compound annual growth rate (CAGR) of 13.1% for the period of 2018-2023.

Bioinformatics: Technologies and Global Markets

Published - Nov 2018 | Publisher - BCC Publishing| Code - BIO051D

The global market for bioinformatics should grow from $6.4 billion in 2017 to reach $16.0 billion by 2022 at a compound annual growth rate (CAGR) of 20.0% for the period of 2017-2022.

Proteomics: Technologies and Global Markets

Published - Oct 2018 | Publisher - BCC Publishing| Code - BIO034E

The global market for proteomics should grow from $7.9 billion in 2017 to $16.8 billion by 2022 at a compound annual growth rate (CAGR) of 16.2% for the period of 2017-2022.

Protein Analysis: Subfocus on Oncoproteomics

Published - Oct 2018 | Publisher - BCC Publishing| Code - BIO168A

The global market for protein analysis should grow from $11.6 billion in 2018 to $19.0 billion by 2023 at a compound annual growth rate (CAGR) of 10.4% from 2018 through 2023.

Genetic Modification Therapies Clinical Applications: Gene Thera...

Published - Sep 2018 | Publisher - BCC Publishing| Code - BIO159A

The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.

Biomarkers: Technologies and Global Markets

Published - Sep 2018 | Publisher - BCC Publishing| Code - BIO061E

The global market for biomarkers should grow from $78.9 billion in 2018 to $136.5 billion by 2023 at a compound annual growth rate (CAGR) of 11.6% from 2018 through 2023.

Next Generation Sequencing for Non-invasive Prenatal Testing: Glo...

Published - Sep 2018 | Publisher - BCC Publishing| Code - BIO173A

The global market for non-invasive prenatal testing (NIPT) should grow from $1.9 billion in 2018 to reach $3.1 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2018-2023.

Global Markets for Enzymes in Industrial Applications

Published - Sep 2018 | Publisher - BCC Publishing| Code - BIO030K

The global industrial enzymes market should reach $7.0 billion by 2023 from $5.5 billion in 2018 at a compound annual growth rate (CAGR) of 4.9% for the period 2018-2023.

Switching to CRISPR-Cas Systems from Uncultivated Microbes

Published - Sep 2018 | Publisher - BCC Publishing| Code - BIO172A

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology is currently the biggest discovery in life science. As a precise gene editing tool, it has been widely used in many areas with a great potential to treat human diseases. While some CRISPR-based therapeutic studies are moving to clinical trials, CRISPR's therapeutic promise was brought into question when some issues were found that could become major obstacles in moving the great genome editing tools to the clinic.While many groups are actively resolving these obstacles, the significant challenges to minimize the immunological risks and avoid potential tumorgenicity have received more attention as big concerns for CRISPR-Cas therapeutics advancing toward the clinic. We believe it is timely to summarize and analyze the emerging immunological risk and potential tumorgenicity with the CRISPR-Cas systems, to predict how this exciting genome editing market will affect other related segments of the entire life science market in the next few years. We also hope our opinion could serve as a "crowd crystal" on those discussions in response to the issues, and bring a better market environment for the technology to be sharpened and advanced into clinical applications.

Current Research & Developments Status of Chimeric Antigen Recept...

Published - Aug 2018 | Publisher - BCC Publishing| Code - BIO162A

The global market for Chimeric Antigen Receptor (CAR) T-cell therapies will grow from nearly $467.0 million in 2018 to $2.9 billion by 2023 at a compound annual growth rate (CAGR) of 44.1% for the period of 2018-2023.

Adoptive Transfer of Autologous Lymphocytes Targeting Somatically...

Published - Aug 2018 | Publisher - BCC Publishing| Code - BIO171A

Adoptive Cell Therapies (ACTs) and the infusion of autologous or redirected tumor-specific T-cells have the potential to drastically impact the treatment of a variety of cancers, especially common epithelial cancers. This report summarizes the current state of clinical research and trials, explains the impact of ACTs on the treatment of several metastasized malignancies, and also raises important concerns about the scalability and compatibility of TILs.

Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnosti...

Published - Aug 2018 | Publisher - BCC Publishing| Code - BIO157A

The global market for polymerase chain reaction (PCR) in point of care (POC) diagnostics totaled $2.9 billion in 2018 and is estimated to reach $4.8 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.6% for the period of 2018-2023.

Microbial Products: Technologies, Applications and Global Markets

Published - Aug 2018 | Publisher - BCC Publishing| Code - BIO086D

The global microbes and microbial products market should reach $302.4 billion by 2023 from $186.3 billion in 2018 at a compound annual growth rate (CAGR) of 10.2% for the period 2018-2023.

Immunohistochemistry (IHC): Global Markets to 2022

Published - Aug 2018 | Publisher - BCC Publishing| Code - BIO161A

The global immunohistochemistry market totaled $1.6 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 7.8% for the period of 2017-2022.

Global Markets for Media, Sera and Reagents in Biotechnology

Published - Aug 2018 | Publisher - BCC Publishing| Code - BIO014K

The global market for media, sera and reagents in biotechnology should reach $5.5 billion by 2023 from $4.1 billion in 2018 at a compound annual growth rate (CAGR) of 6.0% for the period 2018-2023.

Synthetic Biology: Global Markets

Published - Jul 2018 | Publisher - BCC Publishing| Code - BIO066E

The global market for synthetic biology will grow from nearly $4.4 billion in 2017 to $13.9 billion by 2022, with a compound annual growth rate (CAGR) of 26.0% for the period of 2017-2022.

Cardiac Biomarkers: Technologies and Global Markets

Published - Jul 2018 | Publisher - BCC Publishing| Code - BIO128C

The global market for cardiac biomarker will grow from $6.3 billion in 2017 to $9.9 billion by 2022, at a compound annual growth rate (CAGR) of 9.5% for the period of 2017-2022

Digital Polymerase Chain Reaction (PCR) Technology: Global Market...

Published - Jun 2018 | Publisher - BCC Publishing| Code - BIO137B

The global digital polymerase chain reaction (PCR) technology market totaled $425.0 million in 2017 and is estimated to reach $746.0 million by 2022, growing at a compound annual growth rate (CAGR) of 11.9% for the period of 2017-2022.

Exosome Diagnostics and Therapeutics: Global Markets

Published - Jun 2018 | Publisher - BCC Publishing| Code - BIO149B

The global market for exosome industry should reach $180.0 million by 2023 from $25 million in 2018 at a compound annual growth rate (CAGR) of 48.4% for the period 2018-2023.

« 3 4 5 6 7 »

3 Upcoming Reports in Cell Biology

In Vitro Diagnostics (IVD) Quality Controls: Global Market

Target Date - Jun 2022| Publisher - BCC Publishing | Code - BIO233A| Price - $5,500

Get an overview of the global market for in vitro diagnostics (IVD) quality controls market.

Human Recombinant DNA: Global Markets

Target Date - Jul 2022| Publisher - BCC Publishing | Code - BIO232A| Price - $5,500
Report Includes
  • An overview of the global market for human recombinant DNA
  • Estimation of the market size and analyses of global market trends, with data from 2020, 2021 with projections of compound annual growth rates (CAGRs) through 2026
  • Highlights of the market potential for human recombinant DNA, based on product, application, and region
  • Coverage of history and future of human recombinant DNA, and latest technological advancements of the industry
  • Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast
  • Coverage of regulatory landscape, product recalls, pipeline products, and discussion on future perspective, strategies, and developments of the industry
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
  • Company profiles of major players

Cell-based Assays: Technologies and Global Markets

Target Date - Jul 2022| Publisher - BCC Publishing | Code - BIO080E| Price - $5,500
Report Includes
  • An up-to-date review and analysis of the global markets for cell-based assays and related technologies
  • Analyses of the global market trends, with historic sales data from 2020 and 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the current and future market potential for cell-based assays, and areas of focus to forecast this market into various segments and sub-segments
  • Market assessment of the cell-based assays available and currently being used, new developments, spending trends, and revenue prospects for cell-based assays in the pharmaceutical industry
  • Evaluation and forecast the global revenue market size for cell-based assays in biopharmaceuticals, and corresponding market share analysis by type of assay, end user, and region
  • Coverage of major issues involved in the research and development (R&D) of more effective cell-based approaches for drug discovery
  • In-depth information on increasing investments on R&D activities, key technology issues, industry specific challenges, major types of end-user markets, and COVID-19 implications on the progress of this market
  • Descriptive company profiles of the leading global players
 
Get Notified when New Reports are published
MEMBERSHIP

 

CUSTOM